ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bio-coupling Drug Outsourcing Services Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-12Y18999
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Bio coupling Drug Outsourcing Services Market Research Report 2025
BUY CHAPTERS

Global Bio-coupling Drug Outsourcing Services Market Research Report 2025

Code: QYRE-Auto-12Y18999
Report
February 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Companies
Lonza
BSP Pharmaceuticals
Catalent
Merck
Thermo Fisher Scientific
Samsung Biologics
Recipharm
Axplora
Abzena
Fleet Bioprocessing
MabPlex International
Asymchem
Porton Pharma Solutions
WuXi XDC Cayman Inc
Sterling Pharmaceuticals、
NJ Bio, Inc
Piramal Grangemouth
Toyo Pharm
Aobak

Bio-coupling Drug Outsourcing Services Market Size

The global market for Bio-coupling Drug Outsourcing Services was valued at US$ 2675 million in the year 2024 and is projected to reach a revised size of US$ 8725 million by 2031, growing at a CAGR of 18.4% during the forecast period.

Bio-coupling Drug Outsourcing Services Market

Bio-coupling Drug Outsourcing Services Market

Bio-coupling Drug Outsourcing Services are full-process contract research, development and manufacturing services (CRDMO) for pharmaceutical companies, from drug discovery and development to manufacturing, focusing on the development and production of bioconjugated drugs (such as antibody drug conjugate ADCs). These services involve interdisciplinary expertise, including biologics and small molecule drug coupling technologies, and are designed to help pharmaceutical companies efficiently develop and produce highly effective and cytotoxic cancer drugs.
North American market for Bio-coupling Drug Outsourcing Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Bio-coupling Drug Outsourcing Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Bio-coupling Drug Outsourcing Services in Tumor Treatment is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Bio-coupling Drug Outsourcing Services include Lonza, BSP Pharmaceuticals, Catalent, Merck, WuXi XDC Cayman Inc, Thermo Fisher Scientific, Samsung Biologics, Recipharm, Axplora, Sterling Pharmaceuticals、, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bio-coupling Drug Outsourcing Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bio-coupling Drug Outsourcing Services.
The Bio-coupling Drug Outsourcing Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bio-coupling Drug Outsourcing Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bio-coupling Drug Outsourcing Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Bio-coupling Drug Outsourcing Services Market Report

Report Metric Details
Report Name Bio-coupling Drug Outsourcing Services Market
Accounted market size in year US$ 2675 million
Forecasted market size in 2031 US$ 8725 million
CAGR 18.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Antibody Drug Coupling Outsourcing Services
  • Dual Anticoupling Material Outsourcing Services
  • Antibody Oligonucleotide Coupling Outsourcing Services
  • Others
Segment by Application
  • Tumor Treatment
  • Autoimmune Disease Treatment
  • Treatment of Metabolic Disorders
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Lonza, BSP Pharmaceuticals, Catalent, Merck, WuXi XDC Cayman Inc, Thermo Fisher Scientific, Samsung Biologics, Recipharm, Axplora, Sterling Pharmaceuticals、, NJ Bio, Inc, Piramal Grangemouth, Abzena, Fleet Bioprocessing, MabPlex international, Toyo Pharm, Aobak, Asymchem, Porton Pharma Solutions
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Bio-coupling Drug Outsourcing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Bio-coupling Drug Outsourcing Services Market growing?

Ans: The Bio-coupling Drug Outsourcing Services Market witnessing a CAGR of 18.4% during the forecast period 2025-2031.

What is the Bio-coupling Drug Outsourcing Services Market size in 2031?

Ans: The Bio-coupling Drug Outsourcing Services Market size in 2031 will be US$ 8725 million.

Who are the main players in the Bio-coupling Drug Outsourcing Services Market report?

Ans: The main players in the Bio-coupling Drug Outsourcing Services Market are Lonza, BSP Pharmaceuticals, Catalent, Merck, WuXi XDC Cayman Inc, Thermo Fisher Scientific, Samsung Biologics, Recipharm, Axplora, Sterling Pharmaceuticals、, NJ Bio, Inc, Piramal Grangemouth, Abzena, Fleet Bioprocessing, MabPlex international, Toyo Pharm, Aobak, Asymchem, Porton Pharma Solutions

What are the Application segmentation covered in the Bio-coupling Drug Outsourcing Services Market report?

Ans: The Applications covered in the Bio-coupling Drug Outsourcing Services Market report are Tumor Treatment, Autoimmune Disease Treatment, Treatment of Metabolic Disorders, Others

What are the Type segmentation covered in the Bio-coupling Drug Outsourcing Services Market report?

Ans: The Types covered in the Bio-coupling Drug Outsourcing Services Market report are Antibody Drug Coupling Outsourcing Services, Dual Anticoupling Material Outsourcing Services, Antibody Oligonucleotide Coupling Outsourcing Services, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bio-coupling Drug Outsourcing Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antibody Drug Coupling Outsourcing Services
1.2.3 Dual Anticoupling Material Outsourcing Services
1.2.4 Antibody Oligonucleotide Coupling Outsourcing Services
1.2.5 Others
1.3 Market by Application
1.3.1 Global Bio-coupling Drug Outsourcing Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Tumor Treatment
1.3.3 Autoimmune Disease Treatment
1.3.4 Treatment of Metabolic Disorders
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bio-coupling Drug Outsourcing Services Market Perspective (2020-2031)
2.2 Global Bio-coupling Drug Outsourcing Services Growth Trends by Region
2.2.1 Global Bio-coupling Drug Outsourcing Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Bio-coupling Drug Outsourcing Services Historic Market Size by Region (2020-2025)
2.2.3 Bio-coupling Drug Outsourcing Services Forecasted Market Size by Region (2026-2031)
2.3 Bio-coupling Drug Outsourcing Services Market Dynamics
2.3.1 Bio-coupling Drug Outsourcing Services Industry Trends
2.3.2 Bio-coupling Drug Outsourcing Services Market Drivers
2.3.3 Bio-coupling Drug Outsourcing Services Market Challenges
2.3.4 Bio-coupling Drug Outsourcing Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bio-coupling Drug Outsourcing Services Players by Revenue
3.1.1 Global Top Bio-coupling Drug Outsourcing Services Players by Revenue (2020-2025)
3.1.2 Global Bio-coupling Drug Outsourcing Services Revenue Market Share by Players (2020-2025)
3.2 Global Top Bio-coupling Drug Outsourcing Services Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Bio-coupling Drug Outsourcing Services Revenue
3.4 Global Bio-coupling Drug Outsourcing Services Market Concentration Ratio
3.4.1 Global Bio-coupling Drug Outsourcing Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bio-coupling Drug Outsourcing Services Revenue in 2024
3.5 Global Key Players of Bio-coupling Drug Outsourcing Services Head office and Area Served
3.6 Global Key Players of Bio-coupling Drug Outsourcing Services, Product and Application
3.7 Global Key Players of Bio-coupling Drug Outsourcing Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Bio-coupling Drug Outsourcing Services Breakdown Data by Type
4.1 Global Bio-coupling Drug Outsourcing Services Historic Market Size by Type (2020-2025)
4.2 Global Bio-coupling Drug Outsourcing Services Forecasted Market Size by Type (2026-2031)
5 Bio-coupling Drug Outsourcing Services Breakdown Data by Application
5.1 Global Bio-coupling Drug Outsourcing Services Historic Market Size by Application (2020-2025)
5.2 Global Bio-coupling Drug Outsourcing Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Bio-coupling Drug Outsourcing Services Market Size (2020-2031)
6.2 North America Bio-coupling Drug Outsourcing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Bio-coupling Drug Outsourcing Services Market Size by Country (2020-2025)
6.4 North America Bio-coupling Drug Outsourcing Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bio-coupling Drug Outsourcing Services Market Size (2020-2031)
7.2 Europe Bio-coupling Drug Outsourcing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Bio-coupling Drug Outsourcing Services Market Size by Country (2020-2025)
7.4 Europe Bio-coupling Drug Outsourcing Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bio-coupling Drug Outsourcing Services Market Size (2020-2031)
8.2 Asia-Pacific Bio-coupling Drug Outsourcing Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Bio-coupling Drug Outsourcing Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Bio-coupling Drug Outsourcing Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bio-coupling Drug Outsourcing Services Market Size (2020-2031)
9.2 Latin America Bio-coupling Drug Outsourcing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Bio-coupling Drug Outsourcing Services Market Size by Country (2020-2025)
9.4 Latin America Bio-coupling Drug Outsourcing Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bio-coupling Drug Outsourcing Services Market Size (2020-2031)
10.2 Middle East & Africa Bio-coupling Drug Outsourcing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Bio-coupling Drug Outsourcing Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Bio-coupling Drug Outsourcing Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Bio-coupling Drug Outsourcing Services Introduction
11.1.4 Lonza Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
11.1.5 Lonza Recent Development
11.2 BSP Pharmaceuticals
11.2.1 BSP Pharmaceuticals Company Details
11.2.2 BSP Pharmaceuticals Business Overview
11.2.3 BSP Pharmaceuticals Bio-coupling Drug Outsourcing Services Introduction
11.2.4 BSP Pharmaceuticals Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
11.2.5 BSP Pharmaceuticals Recent Development
11.3 Catalent
11.3.1 Catalent Company Details
11.3.2 Catalent Business Overview
11.3.3 Catalent Bio-coupling Drug Outsourcing Services Introduction
11.3.4 Catalent Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
11.3.5 Catalent Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Bio-coupling Drug Outsourcing Services Introduction
11.4.4 Merck Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
11.4.5 Merck Recent Development
11.5 WuXi XDC Cayman Inc
11.5.1 WuXi XDC Cayman Inc Company Details
11.5.2 WuXi XDC Cayman Inc Business Overview
11.5.3 WuXi XDC Cayman Inc Bio-coupling Drug Outsourcing Services Introduction
11.5.4 WuXi XDC Cayman Inc Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
11.5.5 WuXi XDC Cayman Inc Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Bio-coupling Drug Outsourcing Services Introduction
11.6.4 Thermo Fisher Scientific Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Samsung Biologics
11.7.1 Samsung Biologics Company Details
11.7.2 Samsung Biologics Business Overview
11.7.3 Samsung Biologics Bio-coupling Drug Outsourcing Services Introduction
11.7.4 Samsung Biologics Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
11.7.5 Samsung Biologics Recent Development
11.8 Recipharm
11.8.1 Recipharm Company Details
11.8.2 Recipharm Business Overview
11.8.3 Recipharm Bio-coupling Drug Outsourcing Services Introduction
11.8.4 Recipharm Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
11.8.5 Recipharm Recent Development
11.9 Axplora
11.9.1 Axplora Company Details
11.9.2 Axplora Business Overview
11.9.3 Axplora Bio-coupling Drug Outsourcing Services Introduction
11.9.4 Axplora Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
11.9.5 Axplora Recent Development
11.10 Sterling Pharmaceuticals、
11.10.1 Sterling Pharmaceuticals、 Company Details
11.10.2 Sterling Pharmaceuticals、 Business Overview
11.10.3 Sterling Pharmaceuticals、 Bio-coupling Drug Outsourcing Services Introduction
11.10.4 Sterling Pharmaceuticals、 Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
11.10.5 Sterling Pharmaceuticals、 Recent Development
11.11 NJ Bio, Inc
11.11.1 NJ Bio, Inc Company Details
11.11.2 NJ Bio, Inc Business Overview
11.11.3 NJ Bio, Inc Bio-coupling Drug Outsourcing Services Introduction
11.11.4 NJ Bio, Inc Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
11.11.5 NJ Bio, Inc Recent Development
11.12 Piramal Grangemouth
11.12.1 Piramal Grangemouth Company Details
11.12.2 Piramal Grangemouth Business Overview
11.12.3 Piramal Grangemouth Bio-coupling Drug Outsourcing Services Introduction
11.12.4 Piramal Grangemouth Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
11.12.5 Piramal Grangemouth Recent Development
11.13 Abzena
11.13.1 Abzena Company Details
11.13.2 Abzena Business Overview
11.13.3 Abzena Bio-coupling Drug Outsourcing Services Introduction
11.13.4 Abzena Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
11.13.5 Abzena Recent Development
11.14 Fleet Bioprocessing
11.14.1 Fleet Bioprocessing Company Details
11.14.2 Fleet Bioprocessing Business Overview
11.14.3 Fleet Bioprocessing Bio-coupling Drug Outsourcing Services Introduction
11.14.4 Fleet Bioprocessing Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
11.14.5 Fleet Bioprocessing Recent Development
11.15 MabPlex international
11.15.1 MabPlex international Company Details
11.15.2 MabPlex international Business Overview
11.15.3 MabPlex international Bio-coupling Drug Outsourcing Services Introduction
11.15.4 MabPlex international Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
11.15.5 MabPlex international Recent Development
11.16 Toyo Pharm
11.16.1 Toyo Pharm Company Details
11.16.2 Toyo Pharm Business Overview
11.16.3 Toyo Pharm Bio-coupling Drug Outsourcing Services Introduction
11.16.4 Toyo Pharm Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
11.16.5 Toyo Pharm Recent Development
11.17 Aobak
11.17.1 Aobak Company Details
11.17.2 Aobak Business Overview
11.17.3 Aobak Bio-coupling Drug Outsourcing Services Introduction
11.17.4 Aobak Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
11.17.5 Aobak Recent Development
11.18 Asymchem
11.18.1 Asymchem Company Details
11.18.2 Asymchem Business Overview
11.18.3 Asymchem Bio-coupling Drug Outsourcing Services Introduction
11.18.4 Asymchem Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
11.18.5 Asymchem Recent Development
11.19 Porton Pharma Solutions
11.19.1 Porton Pharma Solutions Company Details
11.19.2 Porton Pharma Solutions Business Overview
11.19.3 Porton Pharma Solutions Bio-coupling Drug Outsourcing Services Introduction
11.19.4 Porton Pharma Solutions Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025)
11.19.5 Porton Pharma Solutions Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Companies
Lonza
BSP Pharmaceuticals
Catalent
Merck
Thermo Fisher Scientific
Samsung Biologics
Recipharm
Axplora
Abzena
Fleet Bioprocessing
MabPlex International
Asymchem
Porton Pharma Solutions
WuXi XDC Cayman Inc
Sterling Pharmaceuticals、
NJ Bio, Inc
Piramal Grangemouth
Toyo Pharm
Aobak
List of Tables
 Table 1. Global Bio-coupling Drug Outsourcing Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Antibody Drug Coupling Outsourcing Services
 Table 3. Key Players of Dual Anticoupling Material Outsourcing Services
 Table 4. Key Players of Antibody Oligonucleotide Coupling Outsourcing Services
 Table 5. Key Players of Others
 Table 6. Global Bio-coupling Drug Outsourcing Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Bio-coupling Drug Outsourcing Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Bio-coupling Drug Outsourcing Services Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Bio-coupling Drug Outsourcing Services Market Share by Region (2020-2025)
 Table 10. Global Bio-coupling Drug Outsourcing Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Bio-coupling Drug Outsourcing Services Market Share by Region (2026-2031)
 Table 12. Bio-coupling Drug Outsourcing Services Market Trends
 Table 13. Bio-coupling Drug Outsourcing Services Market Drivers
 Table 14. Bio-coupling Drug Outsourcing Services Market Challenges
 Table 15. Bio-coupling Drug Outsourcing Services Market Restraints
 Table 16. Global Bio-coupling Drug Outsourcing Services Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Bio-coupling Drug Outsourcing Services Market Share by Players (2020-2025)
 Table 18. Global Top Bio-coupling Drug Outsourcing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bio-coupling Drug Outsourcing Services as of 2024)
 Table 19. Ranking of Global Top Bio-coupling Drug Outsourcing Services Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Bio-coupling Drug Outsourcing Services Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Bio-coupling Drug Outsourcing Services, Headquarters and Area Served
 Table 22. Global Key Players of Bio-coupling Drug Outsourcing Services, Product and Application
 Table 23. Global Key Players of Bio-coupling Drug Outsourcing Services, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Bio-coupling Drug Outsourcing Services Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Bio-coupling Drug Outsourcing Services Revenue Market Share by Type (2020-2025)
 Table 27. Global Bio-coupling Drug Outsourcing Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Bio-coupling Drug Outsourcing Services Revenue Market Share by Type (2026-2031)
 Table 29. Global Bio-coupling Drug Outsourcing Services Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Bio-coupling Drug Outsourcing Services Revenue Market Share by Application (2020-2025)
 Table 31. Global Bio-coupling Drug Outsourcing Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Bio-coupling Drug Outsourcing Services Revenue Market Share by Application (2026-2031)
 Table 33. North America Bio-coupling Drug Outsourcing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Bio-coupling Drug Outsourcing Services Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Bio-coupling Drug Outsourcing Services Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Bio-coupling Drug Outsourcing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Bio-coupling Drug Outsourcing Services Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Bio-coupling Drug Outsourcing Services Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Bio-coupling Drug Outsourcing Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Bio-coupling Drug Outsourcing Services Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Bio-coupling Drug Outsourcing Services Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Bio-coupling Drug Outsourcing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Bio-coupling Drug Outsourcing Services Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Bio-coupling Drug Outsourcing Services Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Bio-coupling Drug Outsourcing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Bio-coupling Drug Outsourcing Services Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Bio-coupling Drug Outsourcing Services Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Lonza Company Details
 Table 49. Lonza Business Overview
 Table 50. Lonza Bio-coupling Drug Outsourcing Services Product
 Table 51. Lonza Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
 Table 52. Lonza Recent Development
 Table 53. BSP Pharmaceuticals Company Details
 Table 54. BSP Pharmaceuticals Business Overview
 Table 55. BSP Pharmaceuticals Bio-coupling Drug Outsourcing Services Product
 Table 56. BSP Pharmaceuticals Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
 Table 57. BSP Pharmaceuticals Recent Development
 Table 58. Catalent Company Details
 Table 59. Catalent Business Overview
 Table 60. Catalent Bio-coupling Drug Outsourcing Services Product
 Table 61. Catalent Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
 Table 62. Catalent Recent Development
 Table 63. Merck Company Details
 Table 64. Merck Business Overview
 Table 65. Merck Bio-coupling Drug Outsourcing Services Product
 Table 66. Merck Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
 Table 67. Merck Recent Development
 Table 68. WuXi XDC Cayman Inc Company Details
 Table 69. WuXi XDC Cayman Inc Business Overview
 Table 70. WuXi XDC Cayman Inc Bio-coupling Drug Outsourcing Services Product
 Table 71. WuXi XDC Cayman Inc Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
 Table 72. WuXi XDC Cayman Inc Recent Development
 Table 73. Thermo Fisher Scientific Company Details
 Table 74. Thermo Fisher Scientific Business Overview
 Table 75. Thermo Fisher Scientific Bio-coupling Drug Outsourcing Services Product
 Table 76. Thermo Fisher Scientific Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
 Table 77. Thermo Fisher Scientific Recent Development
 Table 78. Samsung Biologics Company Details
 Table 79. Samsung Biologics Business Overview
 Table 80. Samsung Biologics Bio-coupling Drug Outsourcing Services Product
 Table 81. Samsung Biologics Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
 Table 82. Samsung Biologics Recent Development
 Table 83. Recipharm Company Details
 Table 84. Recipharm Business Overview
 Table 85. Recipharm Bio-coupling Drug Outsourcing Services Product
 Table 86. Recipharm Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
 Table 87. Recipharm Recent Development
 Table 88. Axplora Company Details
 Table 89. Axplora Business Overview
 Table 90. Axplora Bio-coupling Drug Outsourcing Services Product
 Table 91. Axplora Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
 Table 92. Axplora Recent Development
 Table 93. Sterling Pharmaceuticals、 Company Details
 Table 94. Sterling Pharmaceuticals、 Business Overview
 Table 95. Sterling Pharmaceuticals、 Bio-coupling Drug Outsourcing Services Product
 Table 96. Sterling Pharmaceuticals、 Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
 Table 97. Sterling Pharmaceuticals、 Recent Development
 Table 98. NJ Bio, Inc Company Details
 Table 99. NJ Bio, Inc Business Overview
 Table 100. NJ Bio, Inc Bio-coupling Drug Outsourcing Services Product
 Table 101. NJ Bio, Inc Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
 Table 102. NJ Bio, Inc Recent Development
 Table 103. Piramal Grangemouth Company Details
 Table 104. Piramal Grangemouth Business Overview
 Table 105. Piramal Grangemouth Bio-coupling Drug Outsourcing Services Product
 Table 106. Piramal Grangemouth Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
 Table 107. Piramal Grangemouth Recent Development
 Table 108. Abzena Company Details
 Table 109. Abzena Business Overview
 Table 110. Abzena Bio-coupling Drug Outsourcing Services Product
 Table 111. Abzena Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
 Table 112. Abzena Recent Development
 Table 113. Fleet Bioprocessing Company Details
 Table 114. Fleet Bioprocessing Business Overview
 Table 115. Fleet Bioprocessing Bio-coupling Drug Outsourcing Services Product
 Table 116. Fleet Bioprocessing Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
 Table 117. Fleet Bioprocessing Recent Development
 Table 118. MabPlex international Company Details
 Table 119. MabPlex international Business Overview
 Table 120. MabPlex international Bio-coupling Drug Outsourcing Services Product
 Table 121. MabPlex international Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
 Table 122. MabPlex international Recent Development
 Table 123. Toyo Pharm Company Details
 Table 124. Toyo Pharm Business Overview
 Table 125. Toyo Pharm Bio-coupling Drug Outsourcing Services Product
 Table 126. Toyo Pharm Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
 Table 127. Toyo Pharm Recent Development
 Table 128. Aobak Company Details
 Table 129. Aobak Business Overview
 Table 130. Aobak Bio-coupling Drug Outsourcing Services Product
 Table 131. Aobak Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
 Table 132. Aobak Recent Development
 Table 133. Asymchem Company Details
 Table 134. Asymchem Business Overview
 Table 135. Asymchem Bio-coupling Drug Outsourcing Services Product
 Table 136. Asymchem Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
 Table 137. Asymchem Recent Development
 Table 138. Porton Pharma Solutions Company Details
 Table 139. Porton Pharma Solutions Business Overview
 Table 140. Porton Pharma Solutions Bio-coupling Drug Outsourcing Services Product
 Table 141. Porton Pharma Solutions Revenue in Bio-coupling Drug Outsourcing Services Business (2020-2025) & (US$ Million)
 Table 142. Porton Pharma Solutions Recent Development
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Bio-coupling Drug Outsourcing Services Picture
 Figure 2. Global Bio-coupling Drug Outsourcing Services Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Bio-coupling Drug Outsourcing Services Market Share by Type: 2024 VS 2031
 Figure 4. Antibody Drug Coupling Outsourcing Services Features
 Figure 5. Dual Anticoupling Material Outsourcing Services Features
 Figure 6. Antibody Oligonucleotide Coupling Outsourcing Services Features
 Figure 7. Others Features
 Figure 8. Global Bio-coupling Drug Outsourcing Services Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Bio-coupling Drug Outsourcing Services Market Share by Application: 2024 VS 2031
 Figure 10. Tumor Treatment Case Studies
 Figure 11. Autoimmune Disease Treatment Case Studies
 Figure 12. Treatment of Metabolic Disorders Case Studies
 Figure 13. Others Case Studies
 Figure 14. Bio-coupling Drug Outsourcing Services Report Years Considered
 Figure 15. Global Bio-coupling Drug Outsourcing Services Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Bio-coupling Drug Outsourcing Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Bio-coupling Drug Outsourcing Services Market Share by Region: 2024 VS 2031
 Figure 18. Global Bio-coupling Drug Outsourcing Services Market Share by Players in 2024
 Figure 19. Global Bio-coupling Drug Outsourcing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 20. The Top 10 and 5 Players Market Share by Bio-coupling Drug Outsourcing Services Revenue in 2024
 Figure 21. North America Bio-coupling Drug Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Bio-coupling Drug Outsourcing Services Market Share by Country (2020-2031)
 Figure 23. United States Bio-coupling Drug Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Bio-coupling Drug Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Bio-coupling Drug Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Bio-coupling Drug Outsourcing Services Market Share by Country (2020-2031)
 Figure 27. Germany Bio-coupling Drug Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Bio-coupling Drug Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Bio-coupling Drug Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Bio-coupling Drug Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Bio-coupling Drug Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Bio-coupling Drug Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Bio-coupling Drug Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Bio-coupling Drug Outsourcing Services Market Share by Region (2020-2031)
 Figure 35. China Bio-coupling Drug Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Bio-coupling Drug Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Bio-coupling Drug Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Bio-coupling Drug Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Bio-coupling Drug Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Bio-coupling Drug Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Bio-coupling Drug Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Bio-coupling Drug Outsourcing Services Market Share by Country (2020-2031)
 Figure 43. Mexico Bio-coupling Drug Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Bio-coupling Drug Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Bio-coupling Drug Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Bio-coupling Drug Outsourcing Services Market Share by Country (2020-2031)
 Figure 47. Turkey Bio-coupling Drug Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Bio-coupling Drug Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Bio-coupling Drug Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Lonza Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
 Figure 51. BSP Pharmaceuticals Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
 Figure 52. Catalent Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
 Figure 53. Merck Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
 Figure 54. WuXi XDC Cayman Inc Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
 Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
 Figure 56. Samsung Biologics Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
 Figure 57. Recipharm Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
 Figure 58. Axplora Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
 Figure 59. Sterling Pharmaceuticals、 Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
 Figure 60. NJ Bio, Inc Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
 Figure 61. Piramal Grangemouth Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
 Figure 62. Abzena Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
 Figure 63. Fleet Bioprocessing Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
 Figure 64. MabPlex international Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
 Figure 65. Toyo Pharm Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
 Figure 66. Aobak Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
 Figure 67. Asymchem Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
 Figure 68. Porton Pharma Solutions Revenue Growth Rate in Bio-coupling Drug Outsourcing Services Business (2020-2025)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions